← Back to headlines
Biogen and Denali Discontinue Parkinson's Therapy After Trial Setback
Biogen and Denali Therapeutics have announced they will discontinue their Parkinson's disease therapy after it failed to meet expectations in a mid-stage clinical trial.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Diver Killed in Fourth Fatal Shark Attack This Year in Western Australia
2h ago
Weak Earthquake Strikes Near Glina, Croatia
3h ago
Scientists Decipher Mystery of Major 13th-Century Weather Event
4h ago